menu
    • menu

    Company profile for Angiocrine Bioscience

    NEW Drugs in Dev: 2
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Angiocrine Bioscience is a private, clinical stage cell and gene therapy company harnessing the power of genetically modified human endothelial cells to regenerate tissues, restore function and rejuvenate patients with serious medical conditions. Our team is developing a pipeline of proprietary engineered endothelial cell (E-CEL® ) therapies for treating multiple life-threatening hemato-oncologic and immunologic conditions, ...
    Angiocrine Bioscience is a private, clinical stage cell and gene therapy company harnessing the power of genetically modified human endothelial cells to regenerate tissues, restore function and rejuvenate patients with serious medical conditions. Our team is developing a pipeline of proprietary engineered endothelial cell (E-CEL® ) therapies for treating multiple life-threatening hemato-oncologic and immunologic conditions, as well as, regenerating tissues and organs that have been injured or damaged by diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Angiocrine BioscienceUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    11575 Sorrento Valley Road, Suite 217 San Diego, CA 92121
    Telephone
    Telephone
    +1 (877) 784-8496
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://angiocrinebioscience.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/angiocrine-bioscience-inc-/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Angiocrine

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    MAGHREB Pharma Expo

    MAGHREB Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    MAGHREB Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Angiocrine Announces Presentation of AB-205 Trial Data during ASTCT and CIBMTR
    Angiocrine Announces Presentation of AB-205 Trial Data during ASTCT and CIBMTR

    13 Feb 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/angiocrine-bioscience-announces-poster-presentation-of-ab-205-trial-data-during-the-annual-transplantation--cellular-therapy-meetings-of-astct-and-cibmtr-301743676.html

    PR NEWSWIRE
    13 Feb 2023
    Share Share
    Angiocrine has been awarded a $15M Grant for AB-205 Phase 3 Clinical Trial
    Angiocrine has been awarded a $15M Grant for AB-205 Phase 3 Clinical Trial

    19 Dec 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/angiocrine-bioscience-announces-it-has-been-awarded-a-15m-grant-from-the-california-institute-for-regenerative-medicine-for-ab-205-phase-3-clinical-trial-301705571.html

    PRNEWSWIRE
    19 Dec 2022
    Share Share
    Angiocrine Bioscience Announces Presentation of AB-205 Trial during Meeting
    Angiocrine Bioscience Announces Presentation of AB-205 Trial during Meeting

    09 Dec 2022

    // BIONJ

    https://bionj.org/news/pr-newswire-global?rkey=20221209LA59827&filter=16221

    BIONJ
    09 Dec 2022
    Share Share
    Angiocrine Bio Begins Dosing in Pivotal Phase 3 Clinical Trial of AB-205
    Angiocrine Bio Begins Dosing in Pivotal Phase 3 Clinical Trial of AB-205

    29 Mar 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/angiocrine-bioscience-announces-first-patient-dosed-in-pivotal-phase-3-clinical-trial-of-ab-205-in-patients-with-lymphoma-undergoing-autologous-hematopoietic-cell-transplantation-e-celerate-and-completion-of-series-b-financing-301511823.html

    PRNEWSWIRE
    29 Mar 2022
    Share Share
    Angiocrine Bioscience Announces Oral Presentation of AB-205 Data during the 47th
    Angiocrine Bioscience Announces Oral Presentation of AB-205 Data during the 47th

    12 Mar 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/angiocrine-bioscience-announces-oral-presentation-of-ab-205-data-during-the-47th-annual-meeting-of-the-european-society-for-blood-and-marrow-transplantation-301246475.html

    PRNEWSWIRE
    12 Mar 2021
    Share Share
    Angiocrine Bioscience Announces Oral Presentation of AB-205 Data
    Angiocrine Bioscience Announces Oral Presentation of AB-205 Data

    11 Mar 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/angiocrine-bioscience-announces-oral-presentation-of-ab-205-data-during-the-47th-annual-meeting-of-the-european-society-for-blood-and-marrow-transplantation-301246475.html

    PRNEWSWIRE
    11 Mar 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search